ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Gene Expression"

  • Abstract Number: 1330 • 2017 ACR/ARHP Annual Meeting

    Rhesus Theta Defensin 1 (RTD-1) Suppresses Disease-Associated Genes and Induces Anti-Inflammatory Expression Signature in Synovial Tissues of Rat Model of Rheumatoid Arthritis

    Prasad Tongaonkar1, Vasu Punj2, Akshay Subramanian3, Dat Tran3, Katie Trinh4, Justin Schaal1, Percio S. Gulko5, Andre Oullette3 and Michael Selsted3, 1Pathology and Laboratory Medicine, Keck School of Medicine University of Southern California, Los Angeles, CA, 2Medicine, Keck School of Medicine University of Southern California, Los Angeles, CA, 3Keck School of Medicine University of Southern California, Los Angeles, CA, 4Pathology, Keck School of Medicine University of Southern California, Los Angeles, CA, 5Medicine/Rheumatology, Icahn School of Medicine at Mount Sinai, New York, NY

    Background/Purpose: Theta (θ) defensins are the only known macrocyclic peptides found in the Animal kingdom and are exclusively expressed in Old World monkeys. θ-defensins were…
  • Abstract Number: 2347 • 2017 ACR/ARHP Annual Meeting

    High Interferon (IFN) Signatures and Overlapping Clinical Features Characterize Subgroups of Patients with Presumed IFN-Mediated Autoinflammatory Diseases

    Adriana Almeida de Jesus1, Yanfeng Hou2, Louise Malle1, Scott Canna3, Stephen R. Brooks4, Hanna Kim5, Gina A. Montealegre Sanchez1, Rachel VanTries1, Angélique Biancotto6, Samantha Dill5, Dawn C. Chapelle5, Bernadette Marrero1, Yan Huang1 and Raphaela Goldbach-Mansky1, 1Translational Autoinflammatory Disease Studies (TADS), Laboratory of Clinical Investigation and Microbiology (LCIM), NIAID/NIH, Bethesda, MD, 2Department of Rheumatology, Shandong Provincial Qianfoshan Hospital, Shandong University, Shandong, China, 3Richard King Mellon Foundation Institute for Pediatric Research, Children's Hospital of Pittsburgh, Pittsburrgh, PA, 4Biodata Mining and Discovery Section, Office of Science and Technology, NIAMS/NIH, Bethesda, MD, 5Pediatric Translational Research Branch, NIAMS/NIH, Bethesda, MD, 6Center for Human Immunology, Autoimmunity and Inflammation (CHI), NHLBI, NIH, Bethesda, MD

    Background/Purpose: Many pediatric patients (pts.) with early-onset autoinflammatory disease (AID) phenotypes are mutation-negative for genetically known AIDs. Recent data suggest a role for Type-I interferon…
  • Abstract Number: 175 • 2017 ACR/ARHP Annual Meeting

    Precisely Controlled Differential Gene Expression System to Investigate the Effect of eQTL

    Xiaoming Lu, PhD1,2, Xiaoting Chen1, Carmy Forney1, Connor Schroeder1, John B. Harley1, Matthew Weirauch3 and Leah C. Kottyan4, 1Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Immunobiology Graduate Program, University of Cincinnati College of Medicine, Cincinnati, OH, 3Center for Autoimmune Genomics and Etiology (CAGE) and Divisions of Biomedical Informatics and Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Center for Autoimmune Genomics and Etiology (CAGE), Division of Allergy and Immunology, Cincinnati Children's Hospital, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

    Background/Purpose: Genome-wide association studies and large-scale sequencing studies identify many non-coding genetic variants that increase disease risk. At least 60% of these loci have been…
  • Abstract Number: 1406 • 2017 ACR/ARHP Annual Meeting

    Methods for Generating Multiple High-Dimensional Analyses of Cryopreserved Synovial Tissue Developed By the Accelerating Medicines Partnership RA/SLE Network

    Deepak Rao1, Laura T. Donlin2, Kevin Wei3, Nida Meednu4, Jason Turner5, Mandy J. McGeachy6, Fumitaka Mizoguchi7, Joshua Keegan8, James Lederer9, Maria Gutierrez-Arcelus10, Kamil Slowikowski11, Kaylin Muskat12, Joshua Hillman12, Cristina Rozo13, Edd Ricker14, Thomas Eisenhaure15, David Lieb15, Shuqiang Li15, Edward Browne15, Chad Nusbaum15, William H. Robinson16, Stephen Kelly17, Alessandra B. Pernis18, Lionel Ivashkiv19, Susan M. Goodman20, Ellen M. Gravallese21, Michael Holers22, Nir Hacohen23, Costantino Pitzalis17, Peter Gregersen24, Vivian P. Bykerk25, Larry W. Moreland26, Gary Firestein27, Soumya Raychaudhuri28, Andrew Filer29, David L. Boyle30, Michael Brenner10 and Jennifer H. Anolik4, 1Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, 3Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 4Medicine- Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, 5Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom, 6Medicine, University of Pittsburgh, Pittsburgh, PA, 7Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan, 8Brigham and Women's Hospital, Boston, MA, 9Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 10Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 11Division of Medicine and Rheumatology, Brigham and Women's Hospital, Harvard Medical Schoo, Boston, MA, 12University of California, San Diego, San Diego, CA, 13Hospital for Special Surgery, New York, NY, 14Weill Cornell Graduate School of Medical Sciences, New York, NY, 15Broad Institute, Cambridge, MA, 16Stanford University School of Medicine, Stanford, CA, 17Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London, School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, 18David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, 19Medicine, Hospital for Special Surgery, New York, NY, 20Medicine, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 21Lazare Research Bldg, University of Massachusetts Medical School, Worcester, MA, 22Medicine, Division of Rheumatology, University of Colorado Denver, Aurora, CO, 23Harvard Medical School, Boston, MA, 24The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, 252-005, Mt Sinai Hospital, Toronto, ON, Canada, 26Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 27EGG, St Cloud, France, 28Division of Medicine and Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 29Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham, United Kingdom, 30University of California San Diego, La Jolla, CA

    Background/Purpose: Detailed analyses of cells from rheumatoid arthritis (RA) synovium may identify cell phenotypes and functions that drive tissue pathology and joint damage. The AMP…
  • Abstract Number: 2432 • 2017 ACR/ARHP Annual Meeting

    Longitudinal Changes in Gene Expression Associated with Disease Activity during Pregnancy and Post-Partum Among Women with Rheumatoid Arthritis

    Dana E. Goin1,2, Mette Smed3, Nicholas Jewell2, Lior Pachter2,4, J. Lee Nelson5,6, Hanne Kjaergaard3, Jørn Olsen7, Merete Lund Hetland8,9, Bent Ottesen3, Vibeke Zoffmann3 and Damini Jawaheer1,7,10, 1UCSF Benioff Children's Hospital Oakland/CHORI, Oakland, CA, 2University of California, Berkeley, Berkeley, CA, 3Juliane Marie Center, Copenhagen, Denmark, 4California Institute of Technology, Pasadena, CA, 5Fred Hutchinson Cancer Research Center, Seattle, WA, 6University of Washington, Seattle, WA, 7Aarhus University, Aarhus, Denmark, 8The DANBIO registry and the Danish Departments of Rheumatology, Glostrup, Denmark, 9University of Copenhagen, Copenhagen, Denmark, 10University of California, San Francisco, San Francisco, CA

    Background/Purpose: Many women with rheumatoid arthritis (RA) experience an improvement in disease activity during pregnancy, and a predictable flare in the months after they give…
  • Abstract Number: 177 • 2017 ACR/ARHP Annual Meeting

    Intronic Variants of the B-Cell Proliferator RASGRP3 Affect Its Expression, and Might Contribute to Lupus Risk

    Bhupinder Singh1, Philip Borden2, Julio Molineros3, Celi Sun3, Loren Looger2 and Swapan Nath1, 1Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, OKlahoma City, OK, 2Howard Hughes Medical Institute, Ashburn, VA, 3Oklahoma Medical Research Foundation, OKlahoma City, OK

    Background/Purpose: Systemic lupus erythematosus (SLE) is an inflammatory autoimmune disease with complex genetic underpinnings. Variants from RASGRP3 (RAS Guanyl Releasing Protein 3) is one of…
  • Abstract Number: 1411 • 2017 ACR/ARHP Annual Meeting

    Protein Tyrosine Phosphatase Non-Receptor 22 / C-Src Tyrosine Kinase Complex Down-Regulated in Patients with Rheumatoid Arthritis

    Sara Remuzgo-Martínez1, Fernanda Genre1, Raquel López-Mejías1, Santos Castañeda2, Alfonso Corrales1, Pablo Moreno Fresneda2,3, Begoña Ubilla1, Verónica Mijares1, Virginia Portilla1, Jesús González-Vela1, Trinitario Pina1, J. Gonzalo Ocejo-Vinyals4, Juan Irure-Ventura4, Ricardo Blanco1, Javier Martin5, Javier Llorca6 and Miguel Angel González-Gay7, 1Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain, 2Rheumatology Division, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain, 3Rheumatology, Rheumatology Division, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain, 4Immunology Division, Hospital Universitario Marqués de Valdecilla, Santander, Spain, 5Instituto de Parasitología y Biomedicina ‘López-Neyra’, CSIC, PTS Granada, Granada, Spain, 6Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), IDIVAL, Santander, Spain, 7Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL and School of Medicine, University of Cantabria, Santander, Spain

    Background/Purpose: Protein tyrosine phosphatase non-receptor 22 (PTPN22) binds to C-Src tyrosine kinase (CSK) forming a key regulator complex in autoimmunity1. In this regard, PTPN22 is…
  • Abstract Number: 2433 • 2017 ACR/ARHP Annual Meeting

    Transcriptome Analysis in Women with Rheumatoid Arthritis Who Improve or Worsen during Pregnancy

    Dana E. Goin1,2, Mette Smed3, Lior Pachter2,4, Elizabeth Purdom2, J. Lee Nelson5,6, Hanne Kjaergaard3, Jørn Olsen7, Merete Lund Hetland8,9, Bent Ottesen3, Vibeke Zoffmann3 and Damini Jawaheer1,7,10, 1UCSF Benioff Children's Hospital Oakland/CHORI, Oakland, CA, 2University of California, Berkeley, Berkeley, CA, 3Juliane Marie Center, Copenhagen, Denmark, 4California Institute of Technology, Pasadena, CA, 5Immunogenetics, Fred Hutchinson Cancer Rsch, Seattle, WA, 6University of Washington, Seattle, WA, 7Aarhus University, Aarhus, Denmark, 8The DANBIO registry and the Danish Departments of Rheumatology, Glostrup, Denmark, 9University of Copenhagen, Copenhagen, Denmark, 10University of California, San Francisco, San Francisco, CA

    Background/Purpose: Gene expression changes induced by pregnancy in women with rheumatoid arthritis (RA) and healthy women have not been examined. The few studies previously conducted…
  • Abstract Number: 183 • 2017 ACR/ARHP Annual Meeting

    Allele-Dependent Binding of a Viral Protein to Autoimmune Disease-Associated Genetic Variants

    Matthew Weirauch1, Daniel Miller2, Leah C. Kottyan3, Ignacio Ibarra4, Arthur Lynch2, Sayeed Syed5, Xiaoting Chen2, Erin Zoller2, Connor Schroeder2, Josh Lee2, Albert Magnusen6, Ally Yang7, Timothy R. Hughes7, Joo-Seop Park8, Charles Vinson5 and John B. Harley2,9, 1Center for Autoimmune Genomics and Etiology (CAGE) and Divisions of Biomedical Informatics and Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Center for Autoimmune Genomics and Etiology (CAGE), Division of Allergy and Immunology, Cincinnati Children's Hospital, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany, 5NCI, Bethesda, MD, 6Center of Autoimmune Genomics and Etiology (CAGE), Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 7University of Toronto, Toronto, ON, Canada, 8Divisions of Urology and Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 9US Department of Veterans Affairs Medical Center, Cincinnati, OH

    Background/Purpose: Risk factors are known for many diseases, but the etiologies of most autoimmune diseases remain unknown and are idiopathic. Pathogenesis of disease likely involves…
  • Abstract Number: 1413 • 2017 ACR/ARHP Annual Meeting

    Cytokine-Induced Aire Activity in Rheumatoid Arthritis Fibroblast-like Synoviocytes Regulates Expression of Interferon-γ Response Genes

    Beatrice Bergström1, Christina Lundqvist1, Hans Carlsten1, Olov Ekwall2 and Anna-Karin Hultgård Ekwall1, 1Rheumatology and Inflammation Research, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden, 2Dept. of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy University of Gothenburg, Göteborg, Sweden

    Background/Purpose: AIRE is a transcriptional regulator of tissue specific antigens in medullary thymic epithelial cells (mTEC). AIRE orchestrates the negative selection of self-reactive T cells…
  • Abstract Number: 2657 • 2017 ACR/ARHP Annual Meeting

    Single Cell Expression Quantitative Trait Loci (eQTL) Analysis of Established Systemic Lupus Erythematosus (SLE)-Risk Loci in Lupus Patient Monocytes

    Yogita Ghodke-Puranik1, Zhongbo Jin2, Wei Fan3, Mark A. Jensen1, Jessica M. Dorschner2, Danielle Vsetecka2, Shreyasee Amin4, Ashima Makol5, Floranne C. Ernste6, Thomas Osborn4, Kevin Moder4, Vaidehi Chowdhary7 and Timothy Niewold8, 1Colton Center for Autoimmunity, New York University, New York, NY, 2Division of Rheumatology and Department of Immunology, Mayo Clinic, Rochester, MN, 3Department of Rheumatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, China, Shanghai, China, 4Rheumatology, Mayo Clinic, Rochester, MN, 5Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, 6Division of Rheumatology, Mayo Clinic Rochester, Rochester, MN, 7Internal Medicine, Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, 8New York University, New York, NY

    Background/Purpose: Most confirmed SLE-risk loci are found near or in genes with immune function, yet how these loci influence diverse immune cell subsets remains unknown.…
  • Abstract Number: 297 • 2017 ACR/ARHP Annual Meeting

    Multiplexed Characterization of Circulating and Joint-Derived Human Neutrophils in Inflammatory Arthritis

    Ricardo Grieshaber Bouyer1, Olha Halyabar2, Anais Levescot1, Kacie Hoyt2, Lauren Henderson2 and Peter Nigrovic1,2, 1Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Neutrophils are innate immune cells that play a central role in the initiation of inflammatory arthritis as well as mediating tissue damage. We sought…
  • Abstract Number: 1416 • 2017 ACR/ARHP Annual Meeting

    Higher Expression of Type 1 Interferon in Synovitis of Patient with Undifferentiated Arthritis before They Met Rheumatoid Arthritis Criteria Compared to Established Rheumatoid Arthritis.  a Retrospective Study with 14 Years of Follow-up

    Andrea Cuervo1, Raquel Celis2, Julio Ramírez3, Alicia Usategui4, Regina Faré5, M. Victoria Hernández6, Virginia Ruiz-Esquide3, Jose Inciarte-Mundo7, Raimon Sanmarti8, Jose L. Pablos9 and Juan D. Cañete7, 1Arthritis Unit. Rheumatology Dpt, Arthritis Unit, Rheumatology Dpt, Hospital Clinic of Barcelona and IDIBAPS, Barcelona, Spain, 2Arthritis Unit, Rheumatology Department, Arthritis Unit, Rheumatology Dpt, Hospital Clinic of Barcelona and IDIBAPS, Barcelona, Spain, 3Rheumatology Service, Hospital Clínic de Barcelona, Barcelona, Spain, 4Grupo de Enfermedades Inflamatorias y Autoinmunes, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain, 5Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain, 6Hospital Clinic. Barcelona. Spain, Barcelona, Spain, 7Rheumatology Department, Arthritis Unit, Rheumatology Dpt, Hospital Clinic of Barcelona, Barcelona, Spain, 8Arthritis Unit, Rheumatology Dpt, Hospital Clinic of Barcelona, Barcelona, Spain, 9Servicio de Reumatología, Hospital 12 de Octubre, Madrid, Spain

    Background/Purpose: Undifferentiated Arthritis (UA) is defined as an inflammatory oligo/poly arthritis that does not fulfil criteria for a definitive diagnosis.Delay in diagnosis and treatment leads…
  • Abstract Number: 2659 • 2017 ACR/ARHP Annual Meeting

    Development of a Protocol for Single Cell Transcriptomics of Cells from Cryopreserved Lupus Nephritis Kidney Tissue and Urine for the Accelerating Medicines Partnership RA/SLE Network

    Deepak Rao1, Celine C. Berthier2, Arnon Arazi3, Anne Davidson4, Yanyan Liu5, Edward Browne3, Thomas Eisenhaure3, Adam Chicoine6, David Lieb3, Dawn Smilek7, Patti Tosta7, James Lederer8, Michael Brenner5, David Hildeman9, E. Steve Woodle10, David Wofsy11, Jennifer H. Anolik12, Matthias Kretzler13, Nir Hacohen14 and Betty Diamond15, 1Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Nephrology, Division of Nephrology, University of Michigan Medical Center, Ann Arbor, MI, 3Broad Institute, Cambridge, MA, 4Autoimmunity and Musculoskeletal Diseases, Feinstein Inst for Med Rsch, Manhasset, NY, 5Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 6Brigham and Women's Hospital, Boston, MA, 7Immune Tolerance Network, San Francisco, CA, 8Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 9University of Cincinnati, Cincinnati, OH, 10University of Cincinnati College of Medicine, Cincinnati, OH, 11Rheumatology, UCSF, San Francisco, CA, 12Medicine- Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, 13Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, MI, 14Harvard Medical School, Boston, MA, 15Autoimmune and Musculoskeletal Diseases, The Feinstein Institute for Medical Research, Manhasset, NY

    Background/Purpose: There is a critical need to define the cells that mediate tissue damage in lupus nephritis. Here we aimed to establish a protocol to…
  • Abstract Number: 405 • 2017 ACR/ARHP Annual Meeting

    Dynamics of Transcriptional Signatures from Purified Synovial Macrophage Subsets during Acute and Chronic Murine Models of Inflammatory Arthritis

    Philip J. Homan, Salina Dominguez, Harris Perlman, Deborah R. WInter and Carla Cuda, Department of Medicine Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: Rheumatoid arthritis (RA) manifests in persistent synovial inflammation, cellular infiltration and pro-inflammatory cytokine production, resulting in progressive joint destruction. Macrophages have been implicated in…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 31
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology